Table 4.
Group | No. of birds | Vaccinationa | Challenge | Dose | Route |
---|---|---|---|---|---|
A | n = 10 | Yes | NDV-HB12 | 105.0EID50 | Intramuscular injection |
B | n = 10 | Yes | NDV-SD13 | ||
C | n = 10 | Yes | NDV-HB14 | ||
D | n = 5 | No | NDV-HB12 | ||
E | n = 5 | No | NDV-SD13 | ||
F | n = 5 | No | NDV-HB14 | ||
G | n = 10 | Yes | H9-JS12 | 106.0EID50 | Intravenous injection |
H | n = 10 | Yes | H9-HB13 | ||
I | n = 10 | Yes | H9-SD14 | ||
J | n = 5 | No | H9-JS12 | ||
K | n = 5 | No | H9-HB13 | ||
L | n = 5 | No | H9-SD14 | ||
M | n = 5 | No | No | No | No |
aSubcutaneous injection